Terns Pharmaceuticals, Inc. financial data

Symbol
TERN on Nasdaq
Industry
Pharmaceutical Preparations
Location
1065 East Hillsdale Blvd., Suite 100, Foster City, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.28 K % -15.4%
Debt-to-equity 5.08 % +11.7%
Return On Equity -35.6 % -15.5%
Return On Assets -33.8 % -15%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 64.7 M shares +14.1%
Common Stock, Shares, Outstanding 64.7 M shares +14.1%
Entity Public Float 409 M USD +774%
Common Stock, Value, Issued 6 K USD +20%
Weighted Average Number of Shares Outstanding, Basic 74.4 M shares +6.62%
Weighted Average Number of Shares Outstanding, Diluted 74.4 M shares +6.62%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 0 USD -100%
General and Administrative Expense 38.8 M USD +62.9%
Costs and Expenses 104 M USD +43.5%
Operating Income (Loss) -104 M USD -43.5%
Nonoperating Income (Expense) 13.1 M USD +181%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -90.8 M USD -34.1%
Income Tax Expense (Benefit) 276 K USD -30.5%
Net Income (Loss) Attributable to Parent -91.1 M USD -33.7%
Earnings Per Share, Basic -1.26 USD/shares +11.9%
Earnings Per Share, Diluted -1.26 USD/shares +11.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 65.1 M USD -64.7%
Marketable Securities, Current 176 M USD +55.1%
Assets, Current 246 M USD -17.9%
Property, Plant and Equipment, Net 447 K USD -34.6%
Operating Lease, Right-of-Use Asset 369 K USD -59%
Other Assets, Noncurrent 55 K USD +48.6%
Assets 247 M USD -18.1%
Accounts Payable, Current 1.7 M USD -36.8%
Employee-related Liabilities, Current 2.1 M USD +152%
Liabilities, Current 8.83 M USD -27.1%
Accrued Income Taxes, Noncurrent 1.22 M USD +10%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 10 M USD -26.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -321 K USD +22.8%
Retained Earnings (Accumulated Deficit) -355 M USD -34.5%
Stockholders' Equity Attributable to Parent 237 M USD -17.7%
Liabilities and Equity 247 M USD -18.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -22.8 M USD -58.5%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 8 M USD -71.4%
Common Stock, Shares Authorized 150 M shares 0%
Common Stock, Shares, Issued 64.7 M shares +14.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -14.8 M USD -136%
Deferred Tax Assets, Valuation Allowance 59.6 M USD +41.3%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 182 K USD -38.1%
Operating Lease, Liability 427 K USD -59%
Depreciation 300 K USD -40%
Payments to Acquire Property, Plant, and Equipment 29 K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -91 M USD -34.5%
Lessee, Operating Lease, Liability, to be Paid 435 K USD -60.2%
Property, Plant and Equipment, Gross 2.12 M USD -2.04%
Operating Lease, Liability, Current 427 K USD -34.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 850 K USD +27.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) -19 K USD -135%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 8 K USD -84.6%
Deferred Tax Assets, Operating Loss Carryforwards 19.9 M USD +44%
Current Income Tax Expense (Benefit) 258 K USD -15.1%
Preferred Stock, Shares Authorized 10 M shares 0%
Unrecognized Tax Benefits 7.51 M USD +18.8%
Additional Paid in Capital 592 M USD +7.25%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 14 K USD +180%
Current Federal Tax Expense (Benefit) 5 K USD
Depreciation, Depletion and Amortization 82 K USD +7.9%
Share-based Payment Arrangement, Expense 25.6 M USD +114%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%